Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients

Clinical trial NCT00411645 · COMPLETED

Trial details

NCT number: NCT00411645
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2006-12-13
Primary completion: 2008-11-10
Enrollment: 681

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.